Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000299387, described as novel transcript, sense intronic to SPIDR, is a predicted long non-coding RNA (lncRNA) gene located within the intronic region of the protein-coding gene SPIDR on the sense DNA strand. This annotation signifies that it does not encode a protein product, and there is currently no information about specific molecular function, involvement in signaling pathways, or therapeutic relevance. There are no reported aliases beyond the systematic description. No approved drugs, clinical candidates, or mechanisms of molecular targeting are associated with this transcript, and its biological function and disease links have yet to be determined in the scientific literature or major databases. No evidence exists to support use as a therapeutic target or as a biomarker, nor are there known safety concerns related to its modulation. Given current knowledge, this transcript is best considered as an uncharacterized lncRNA within the human genome, with a need for further research to determine its biological significance, if any.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, sense intronic to SPIDR (ENSG00000299387).